CSPC Pharmaceutical Group saw the highest growth of 1.12% in patent filings and 1.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.12% and grants by 1.49%. GlobalData’s DataBook provides a comprehensive analysis of CSPC Pharmaceutical Group’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
CSPC Pharmaceutical Group has been focused on protecting inventions in China(CN) with 17 publications in Q2 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 40% filings and 60% grants. The China(CN), United States(US), European Patent Office(EPO), and South Korea(KR) patent Office are among the top ten patent offices where CSPC Pharmaceutical Group is filings its patents. Among the top granted patent authorities, CSPC Pharmaceutical Group has 60% of its grants in China(CN), 13% in Australia(AU) and 7% in European Patent Office(EPO).
Roche and Johnson & Johnson could be the strongest competitors for CSPC Pharmaceutical Group
Patents related to nanomedicine and rare diseases lead CSPC Pharmaceutical Group's portfolio
CSPC Pharmaceutical Group has the highest number of patents in nanomedicine followed by, rare diseases and climate change. For nanomedicine, nearly 50% of patents were filed and 33% of patents were granted in Q2 2024.
Mobiles, hand-helds, pdas, smartphones related patents lead CSPC Pharmaceutical Group portfolio followed by breast cancer, and liver diseases
CSPC Pharmaceutical Group has highest number of patents in mobiles, hand-helds, pdas, smartphones followed by breast cancer, liver diseases, manufacturing/industrial, and lymphoma. For mobiles, hand-helds, pdas, smartphones, nearly 6% of patents were filed and 3% of patents were granted in Q2 2024.
For comprehensive analysis of CSPC Pharmaceutical Group's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
